Professional Documents
Culture Documents
URRENT
C
OPINION
Purpose of review
The use of dietary supplements in sports is widespread as athletes are continuously searching for strategies
to increase performance at the highest level. Beta-alanine is such a supplement that became increasingly
popular during the past years. This review examines the available evidence regarding the optimization of
supplementation, the link between beta-alanine and exercise performance and the underlying ergogenic
mechanism.
Recent findings
It has been repeatedly demonstrated that chronic beta-alanine supplementation can augment intramuscular
carnosine content. Yet, the factors that determine the loading process, as well as the mechanism by which
this has an ergogenic effect, are still debated. On the basis of its biochemical properties, several functions
are ascribed to carnosine, of which intramuscular pH buffer and calcium regulator are the most cited ones.
In addition, carnosine has antiglycation and antioxidant properties, suggesting it could have a therapeutic
potential.
Summary
On the basis of the millimolar presence of carnosine in mammalian muscles, it must play a critical role in
skeletal muscle physiology. The recent number of studies shows that this is related to an improved exercise
homeostasis and excitation-contraction coupling. Recent developments have led to the optimization of the
beta-alanine supplementation strategies to elevate muscle carnosine content, which are helpful in its
application in sports and to potential future therapeutic applications.
Keywords
dietary supplement, high-intensity exercise performance, L-carnosine, pH buffering
INTRODUCTION
Beta-alanine has become a popular dietary supplement among competitive athletes participating in
a range of sports. The rationale for this is based on
well substantiated evidence that beta-alanine
supplementation is able to increase intramuscular
L-carnosine (beta-alanyl-L-histidine) concentrations. This carnosine loading may thereby augment
fatigue threshold and improve high-intensity
exercise performance. Carnosine is a cytoplasmic
dipeptide combining the proteinogenic amino acid
L-histidine with the nonproteinogenic beta-amino
acid beta-alanine and occurs in high concentrations
in human skeletal muscle (58 mmol/l wet weight)
that makes carnosine one of the most abundant
intramuscular molecular compounds. Almost a
decade ago, Harris et al. [1] were the first to demonstrate that chronic beta-alanine supplementation is
able to increase muscle carnosine concentration,
suggesting that beta-alanine is the rate-limiting
factor for the dipeptide synthesis. Shortly after this
www.co-clinicalnutrition.com
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
KEY POINTS
Chronic beta-alanine supplementation increases muscle
carnosine concentration, subsequently leading to an
improved performance in high-intensity exercises.
Exercise training and meal coingestion can improve
efficiency of oral beta-alanine supplementation toward
muscle carnosine loading.
The ergogenic effect of beta-alanine supplementation is
equally effective in trained and untrained individuals.
The carnosine shuttle hypothesis implies that carnosine
can work as a Ca2/H exchanger by improving
calcium delivery to and proton removal from the
sarcomere site.
&
Table 1. Summary of the efficiency of beta-alanine supplementation for different supplementation studies, showing that meal
co-ingestion, exercise training and high daily intakes during a limited period lead to highest efficiency of beta-alanine-induced
carnosine loading
Study
Dose
Meal
Training
Stegen et al. [5 ]
Pure
2.39
Stegen et al. [5 ]
Slow-release
2.76
Stegen et al. [5 ]
Pure
2.99
Bex et al. [6 ]
Slow-release
3.49
Slow-release
5.65
Bex et al. [6 ]
Slow-release
5.82
&
&
&
&
&
&
Beta-alanine form
Efficiency (%)
&
All studies measured carnosine in both soleus and gastrocnemius muscles, and efficiency was calculated as the average of both muscle types. Stegen et al. [5 ]
&
used physically active students, Bex et al. [6 ] used nonathletes and kayakers (untrained muscles), cyclists and swimmers (trained muscles) and Chung et al.
&
[20 ] used well trained cyclists/triathletes. Beta-alanine efficiency is calculated by dividing the total molar increase in muscle carnosine (40% of body
weight D[muscle carnosine]) by the total ingested molar amount of beta-alanine.
64
www.co-clinicalnutrition.com
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
&
&
&
www.co-clinicalnutrition.com
65
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
66
www.co-clinicalnutrition.com
&
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
&
&&
www.co-clinicalnutrition.com
67
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
H+
Muscle fiber
SR
Ca++
Ca++
H+
Ca++
O
Ca++ -carn
HO
O
Carnosine
shuttle
Ca++ -carn
H+ -carn
H+
Glucose
H
N
H+ -carn
Ca++
NH
NH2
Cross-bridges
ATP
FIGURE 1. Current hypothesis on the ergogenic mechanism of carnosine in skeletal muscle, based on the findings of Swietach
et al. [41 ] in cardiac myocytes. It poses that carnosine can act as a shuttle by transporting both H and Ca2 between the
sarcomere region and the subsarcolemmal/T-tubular region. This would improve calcium delivery to and proton removal from
the sarcomere site. Inset shows molecular structure of carnosine with indication (arrow) of competitive binding site of H and
Ca2. SR, sarcoplasmic reticulum.
&&
carnosine shuttle, would explain much of the ergogenic effects of muscle carnosine loading (Fig. 1).
68
www.co-clinicalnutrition.com
12-week supplementation period, although carnosine contents were not measured in this study. On
the basis of these studies, beta-alanine supplementation possibly represents one of the few evidencebased dietary interventions that may delay the
decrease in exercise capacity with aging.
Because of the health-protective functions that
carnosine possesses [36 ], it could be believed that
next to the presence of carnosine in muscle, also the
presence in plasma could have therapeutic benefits.
However, in humans, circulating carnosine is
readily degraded by the highly active serum carnosinase enzyme (CN1), mostly resulting in a low or
even nonmeasurable plasma carnosine concentrations after supplementation or dietary ingestion.
Though, Everaert et al. [45] found that people with
low CN1 activity and content show measurable
increases in carnosinemia following carnosine
ingestion in a dose (60 mg/kg body weight) far
exceeding the normal dietary intake [36 ]. Thereupon, the relevance of low serum CN1 activity
toward athletic populations was demonstrated, as
it was shown that explosive athletes at an elite level
have lower serum CN1 activity and content,
possibly resulting from genetic selection [46 ]. However, regarding the therapeutic potential of plasma
carnosine, most studies are conducted in animal
&
&
&
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
CONCLUSION
Although carnosine has been discovered more than
a century ago, many aspects still need to be elucidated in order to get a complete understanding of
this multipotent dipeptide. Currently, beta-alanine
is already taken by a lot of athletes, but the metabolic fate of ingested beta-alanine is still mainly
unknown. The majority of the available evidence
supports the ergogenic potential of beta-alanine
supplementation for certain types of exercise, with
more work still required in applied sport-specific
settings. Clearly, the mechanisms by which
enhanced muscle carnosine concentrations result
in improved exercise performance need to be refined
in detail, with particular focus that it most likely
involves a complex interaction between pH buffering, Ca2-handling or other accessory functions.
Compared to the ergogenic potential, research on
the therapeutic potential of carnosine is still in its
infancy, with the need to further discover which
populations have reduced muscle carnosine concentrations and which ones benefit from increasing
plasma and/or muscle carnosine content.
Acknowledgements
The studies on beta-alanine and carnosine from our
research groups were financially supported by grants
from the Research Foundation, Flanders (FWO
G.0243.11 and G.0352.13N).
Conflicts of interest
There are no conflicts of interest.
www.co-clinicalnutrition.com
69
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
70
www.co-clinicalnutrition.com
39. Dutka TL, Lamboley CR, McKenna MJ, et al. Effects of carnosine on contractile apparatus Ca2 sensitivity and sarcoplasmic reticulum Ca2 release
in human skeletal muscle fibers. J Appl Physiol (1985) 2012; 112:728
736.
40. Everaert I, Stegen S, Vanheel B, et al. Effect of beta-alanine and carnosine
supplementation on muscle contractility in mice. Med Sci Sports Exerc 2013;
45:4351.
41. Swietach P, Youm J-B, Saegusa N, et al. Coupled Ca2/H transport by
&&
cytoplasmic buffers regulates local Ca2 and H ion signaling. Proc Natl
Acad Sci U S A 2013; 110:E2064E2073.
In this excellent study, the pH buffering role and the Ca2 handling role of
carnosine were shown to interact in cardiomyocytes, and it provides at present
the best available hypothesis on the understanding of the ergogenic mechanism of
carnosine.
42. Swietach P, Leem C-H, Spitzer KW, Vaughan-Jones RD. Pumping Ca2 ions
up H gradients: a cytoplasmic Ca2/H exchanger without a membrane.
J Physiol 2014; 592:31793188.
43. Del Favero S, Roschel H, Solis MY, et al. Beta-alanine (CarnosynTM) supplementation in elderly subjects (60-80 years): effects on muscle carnosine
content and physical capacity. Amino Acids 2012; 43:4956.
44. McCormack WP, Stout JR, Emerson NS, et al. Oral nutritional supplement
fortified with beta-alanine improves physical working capacity in older adults:
a randomized, placebo-controlled study. Exp Gerontol 2013; 48:933
939.
45. Everaert I, Taes Y, De Heer E, et al. Low plasma carnosinase activity promotes
carnosinemia after carnosine ingestion in humans. Am J Physiol Renal Physiol
2012; 302:F1537F1544.
46. Baguet A, Everaert I, Yard B, et al. Does low serum carnosinase activity
&
favor high-intensity exercise capacity? J Appl Physiol 2014; 116:553
559.
The main finding of this study was the low serum carnosinase (CN1) activity and
content in explosive athletes, suggesting a relevance of this enzyme toward
exercise performance.
47. Aldini G, Orioli M, Rossoni G, et al. The carbonyl scavenger carnosine
ameliorates dyslipidaemia and renal function in Zucker obese rats. J Cell
Mol Med 2011; 15:13391354.
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.